lysergic acid has been researched along with ly 215840 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloomquist, WE; Cohen, ML; Robertson, DW; Wilson, HC | 1 |
| Bean, JS; Bloomquist, WE; Cohen, ML; Kauffman, RF | 1 |
| Cohen, ML; Cushing, DJ; Nelson, DL; Zgombick, JM | 1 |
| Brooks, SA; Lachno, DR; Obermeyer, BD | 1 |
| Terrón, JA | 1 |
| Meneses, A; Terrón, JA | 1 |
| Durairaj, H; Parameswaran, N; Steury, MD | 1 |
7 other study(ies) available for lysergic acid and ly 215840
| Article | Year |
|---|---|
LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis.
Topics: Administration, Oral; Animals; Cerebrovascular Circulation; Humans; Lysergic Acid; Male; Models, Cardiovascular; Muscle, Smooth, Vascular; Platelet Aggregation; Platelet Aggregation Inhibitors; Pressoreceptors; Rabbits; Rats; Rats, Inbred Strains; Serotonin Antagonists; Thrombosis; Vasoconstriction | 1992 |
Vascular serotonin 5-hydroxytryptamine2 receptor blockade by LY215840: lack of effect upon neointima formation in balloon-injured rat carotid arteries.
Topics: Animals; Carotid Artery Diseases; Carotid Artery, Common; Catheterization; Cell Division; Disease Models, Animal; Heparin; Lysergic Acid; Male; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Tunica Intima | 1993 |
LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery.
Topics: Animals; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Humans; Lysergic Acid; Muscle, Smooth, Vascular; Radioligand Assay; Serotonin; Serotonin Antagonists | 1996 |
Automated high-performance liquid chromatographic method for the analysis of two novel ergoline compounds in human plasma.
Topics: Chromatography, High Pressure Liquid; Drug Stability; Humans; Lysergic Acid; Sensitivity and Specificity; Serotonin Antagonists | 1997 |
Antagonism of the relaxant 5-HT receptor in the dog basilar artery by the high-affinity 5-HT7 receptor ligand, LY215840.
Topics: Animals; Basilar Artery; Dinoprost; Dogs; Dose-Response Relationship, Drug; In Vitro Techniques; Ketanserin; Lysergic Acid; Muscle Relaxation; Muscle, Smooth, Vascular; Oxadiazoles; Piperazines; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1998 |
Role of 5-HT(1A) and 5-HT(7) receptors in the facilitatory response induced by 8-OH-DPAT on learning consolidation.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Appetitive Behavior; Brain; Conditioning, Classical; Dose-Response Relationship, Drug; Lysergic Acid; Male; Mental Recall; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists | 2001 |
Paroxetine differentially modulates LPS-induced TNFα and IL-6 production in mouse macrophages.
Topics: Animals; Cell Line; Fluoxetine; Interleukin-6; Lipopolysaccharides; Lysergic Acid; Macrophages; Mice, Inbred C57BL; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Tumor Necrosis Factor-alpha | 2015 |